S. Verelst
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer survivorship and care
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 11
- Chronic Myeloid Leukemia Treatments 1
- Oncology 6
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Pieter Sonneveld (11 shared papers)Hedwig M. Blommestein (8 shared papers)Allert H. Vos (1 shared paper)Lonneke V. van de Poll‐Franse (1 shared paper)Floortje Mols (1 shared paper)Ad Koster (1 shared paper)Simone Oerlemans (1 shared paper)Peter C. Huijgens (6 shared papers)
- Journals
- Blood (4 papers)Annals of Hematology (2 papers)European Journal Of Haematology (2 papers)HemaSphere (1 paper)Value in Health (1 paper)
- Partner nations
- NetherlandsSwitzerlandUnited Kingdom
In The Last Decade
S. Verelst
12 papers receiving 329 citations
Peers
Comparison fields: 5 of 42
- Hematology 263
- Oncology 129
- Genetics 27
- Transplantation 4
- Molecular Biology 80
Countries citing papers authored by S. Verelst
This map shows the geographic impact of S. Verelst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Verelst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Verelst more than expected).
Fields of papers citing papers by S. Verelst
This network shows the impact of papers produced by S. Verelst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Verelst. The network helps show where S. Verelst may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Verelst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 101 | |
| 2 | 2013 | 80 | |
| 3 | 2012 | 47 | |
| 4 | 2018 | 41 | |
| 5 | 2011 | 31 | |
| 6 | 2015 | 28 | |
| 7 | 2010 | 5 | |
| 8 | Access to expensive cancer drugs in Dutch daily practice: should we be concerned? | 2014 | 4 |
| 9 | 2011 | 3 | |
| 10 | 2020 | 2 | |
| 11 | 2012 | 1 | |
| 12 | 2013 | 1 | |
| 13 | 2013 | 1 | |
| 14 | 2015 | 1 |
About S. Verelst
S. Verelst is a scholar working on Hematology, Oncology, Molecular Biology, Surgery and Infectious Diseases, having authored 14 papers that have together received 346 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Cancer Treatment and Pharmacology (4 papers), Protein Degradation and Inhibitors (3 papers), Peptidase Inhibition and Analysis (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Pneumothorax, Barotrauma, Emphysema (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Hematology (263 citations), Oncology (129 citations), Genetics (27 citations), Transplantation (4 citations) and Molecular Biology (80 citations). S. Verelst has collaborated with scholars based in Netherlands, Switzerland and United Kingdom. Frequent co-authors include Pieter Sonneveld, Hedwig M. Blommestein, Allert H. Vos, Lonneke V. van de Poll‐Franse, Floortje Mols, Ad Koster, Simone Oerlemans, Peter C. Huijgens, Carin A. Uyl‐de Groot and Maria Teresa Petrucci. Their work appears in journals such as Blood, Annals of Hematology, European Journal Of Haematology, HemaSphere and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.